Research News

- Read more about Some Herbal and Dietary Supplements Can Be Toxic to the Live
A new review based on a research symposium sponsored by the American Association for the Study of Liver Disease and the National Institutes of Health highlights the potentially damaging effects of herbal and dietary supplements (HDSs) on the liver.
- Read more about Antibiotics developed in 1960s show promise for TB therapy
First generation cephalosporins antibiotics introduced as a treatment against bacterial infections in 1963 now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.
- Read more about Skin cancer: drug combination could improve immunotherapy
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center (CCC) show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments. However, the results also show that this combination can lead to an increase in side-effects. The CCC is therefore now looking for ways to improve the side-effect profile and is testing these approaches in two upcoming studies.
- Read more about Broadly neutralizing HIV antibodies pave the way for vaccine
A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. Researchers from the University of Zurich and University Hospital Zurich now reveal which factors are responsible for the human body forming such broadly neutralizing HIV antibodies, thereby opening new avenues for the development of an HIV vaccine.
- Read more about Blood pressure drug may boost effectiveness of lung cancer treatment
A blood pressure drug may make a type of lung cancer treatment more effective, suggests a new study.The early-stage research, conducted on human cells in the lab and on mice, was led by scientists from Imperial College London and Fudan University in China, and is published in the journal Cell Discovery.
- Read more about SMT Expands Global Footprint
Sahajanand Medical Technologies Pvt. Ltd. (SMT), India’s largest manufacturer of cardiovascular medical stents today announced the opening of its new Research & Development Centre in Galway City, Ireland. SMT aims to attract global talent through this new facility in Ireland to diversify its product portfolio. The company has significant investment plans to develop this R&D Centre.
- Read more about Blood Cancer Drugs Leading Growth in Global Hematology Market : Reports BCC Research
Incidence and mortality rates for most cancers are increasing in emerging countries, mostly due to the adoption of unhealthy Western lifestyles such as smoking, physical inactivity, and diet. BCC Research reveals in its new report that the hematological cancer drug sector is leading growth in the global market for hematology drugs and diagnostics.
- Read more about Treatments for Dementia and Alzheimer's Disease possible with Chinese medicine
A new study of classical Chinese medical texts identifies references to age-related memory impairment similar to modern-day Alzheimer's disease, and to several plant-based ingredients used centuries ago -- and still in use today -- to treat memory impairment. Experimental studies of five of these traditional Chinese medicines suggest that they have biological activity relevant to Alzheimer's disease, according to an article in The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc.
- Read more about The Scripps Research Institute Study Illuminates How Mystery MS Drug Works
A study by scientists at The Scripps Research Institute (TSRI) has helped to de-mystify the molecular workings of the multiple sclerosis (MS) drug Tecfidera®. The drug is the most widely prescribed pill-based therapy for MS, but its biological mechanism remains mysterious.
- Read more about Computational method identifies existing drugs with virus-fighting potential
A new, computer-based screening method could reveal the virus-fighting potential of drugs originally developed to treat other conditions, reports a study in PLOS Computational Biology.